Conference Proceedings
Darbepoetin alfa given once every 3 weeks (Q3W) either synchronously or asynchronously with Q3W chemotherapy (ctx) improves anaemia in patients with breast cancer: results of a randomised, open-label study
M Rahn Kim, J Glaspy, D Henry, R Patel, NS Tchekmedyian, R Berg
EJC SUPPLEMENTS | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2004